Concepts (44)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Purinergic P2X7 | 3 | 2022 | 6 | 1.530 |
Why?
|
| Glioma | 2 | 2021 | 123 | 1.210 |
Why?
|
| Nucleotides | 1 | 2022 | 20 | 0.750 |
Why?
|
| Neoplasms | 1 | 2022 | 887 | 0.390 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 121 | 0.360 |
Why?
|
| Cell Line, Tumor | 3 | 2026 | 1362 | 0.300 |
Why?
|
| Signal Transduction | 3 | 2025 | 1502 | 0.260 |
Why?
|
| Rats | 2 | 2021 | 1595 | 0.260 |
Why?
|
| Killer Cells, Natural | 1 | 2026 | 73 | 0.230 |
Why?
|
| Myosin Heavy Chains | 1 | 2025 | 25 | 0.230 |
Why?
|
| Mitochondria, Muscle | 1 | 2025 | 44 | 0.230 |
Why?
|
| Keratinocytes | 1 | 2024 | 33 | 0.210 |
Why?
|
| Testis | 1 | 2024 | 40 | 0.200 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2024 | 45 | 0.200 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 59 | 0.200 |
Why?
|
| Energy Metabolism | 1 | 2025 | 217 | 0.200 |
Why?
|
| Adenosine | 1 | 2022 | 33 | 0.190 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 88 | 0.180 |
Why?
|
| Animals | 4 | 2026 | 10802 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 645 | 0.160 |
Why?
|
| Purinergic P2X Receptor Agonists | 1 | 2020 | 2 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2026 | 556 | 0.160 |
Why?
|
| Cell Membrane Permeability | 1 | 2020 | 44 | 0.160 |
Why?
|
| Calcium Signaling | 1 | 2020 | 72 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2021 | 828 | 0.140 |
Why?
|
| Cell Survival | 1 | 2020 | 422 | 0.140 |
Why?
|
| RNA, Messenger | 1 | 2020 | 669 | 0.130 |
Why?
|
| Humans | 4 | 2026 | 29202 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2026 | 52 | 0.060 |
Why?
|
| Mice | 2 | 2026 | 4867 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2025 | 183 | 0.050 |
Why?
|
| Glycolysis | 1 | 2025 | 96 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2026 | 159 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2026 | 205 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 302 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2026 | 171 | 0.050 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2026 | 153 | 0.050 |
Why?
|
| Epidermis | 1 | 2024 | 11 | 0.050 |
Why?
|
| Protein Stability | 1 | 2024 | 43 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 878 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2026 | 1524 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 646 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 1684 | 0.040 |
Why?
|
| Male | 2 | 2025 | 14120 | 0.040 |
Why?
|